INDRAYANI BIOTECH
|
INDRAYANI BIOTECH Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹-6.11 Cr | ₹10 Cr | ₹12 Cr | ₹4.44 Cr | ₹-11 Cr |
| Adjustment | ₹16 Cr | ₹14 Cr | ₹9.37 Cr | ₹2.52 Cr | ₹4.52 Cr |
| Changes In working Capital | ₹-18 Cr | ₹-54 Cr | ₹-5.11 Cr | ₹-2.85 Cr | ₹6.95 Cr |
| Cash Flow after changes in Working Capital | ₹-7.91 Cr | ₹-30 Cr | ₹16 Cr | ₹4.11 Cr | ₹0.26 Cr |
| Cash Flow from Operating Activities | ₹-6.74 Cr | ₹-30 Cr | ₹16 Cr | ₹4.11 Cr | ₹0.26 Cr |
| Cash Flow from Investing Activities | ₹25 Cr | ₹-16 Cr | ₹-47 Cr | ₹-0.56 Cr | ₹-0.70 Cr |
| Cash Flow from Financing Activities | ₹-18 Cr | ₹44 Cr | ₹33 Cr | ₹-2.73 Cr | ₹-0.28 Cr |
| Net Cash Inflow / Outflow | ₹-0.29 Cr | ₹-2.45 Cr | ₹1.53 Cr | ₹0.82 Cr | ₹-0.72 Cr |
| Opening Cash & Cash Equivalents | ₹0.58 Cr | ₹3.04 Cr | ₹1.50 Cr | ₹0.68 Cr | ₹1.40 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹0.29 Cr | ₹0.58 Cr | ₹3.04 Cr | ₹1.50 Cr | ₹0.68 Cr |
Compare Cashflow Statement of peers of INDRAYANI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAYANI BIOTECH | ₹63.7 Cr | -6.4% | -10.6% | -62.2% | Stock Analytics | |
| No other companies found in this Industry | ||||||
INDRAYANI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAYANI BIOTECH | -6.4% |
-10.6% |
-62.2% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses